Study guide
10.3 Point-of-Care and Waived Chemistry Testing
AMT Certified Medical Laboratory Assistant CMLA
Track your progress as you read
Finished sections get a check mark.
1 Introduction
1.1 Current Exam Facts 1.2 Blueprint Weights and Study Strategy
2 Chapter 2: Safety Terminology and Infection Control
2.1 Safety, Infection, and OSHA Terminology 2.2 Chain of Infection and Precautions 2.3 Isolation, Aseptic Technique, and Disease Prevention
3 Chapter 3: OSHA, HazCom, and Public-Health Reporting
3.1 OSHA Bloodborne Pathogens and Needlestick Safety 3.2 Hazard Communication, SDS, and GHS 3.3 Mandated Safety Rules and Public-Health Reporting
4 Chapter 4: Quality Assessment and Quality Control
4.1 Quality Control and Assessment Terminology 4.2 QC vs QA, Internal vs External QC, and Proficiency Testing 4.3 Daily QC, Temperature Logs, and Corrective Action 4.4 Instrument Maintenance and Calibration in CMLA Scope
5 Chapter 5: Waived-Test Integrity and Confirmatory Testing
5.1 Off-Label Waived Testing and High-Complexity Default 5.2 Following Manufacturer Instructions for Waived Tests 5.3 Confirmatory and Supplemental Testing
6 Chapter 6: Phlebotomy Foundations
6.1 Phlebotomy Terminology and Equipment 6.2 Serum, Plasma, Whole Blood, and Anticoagulation 6.3 Patient Identification and Container Identification
7 Chapter 7: Venipuncture, Order of Draw, and Specimen Integrity
7.1 Patient Preparation and Physiologic Effects 7.2 Vein Selection and Venipuncture Technique 7.3 Order of Draw and Tube Additives 7.4 Short Draws, Hemolysis, and Plasma-on-Cells Limits
8 Chapter 8: Capillary Collection, Processing, and Legal Specimens
8.1 Capillary Puncture Including Infants 8.2 Post-Care, Labeling, Transport, Processing, and Send-Outs 8.3 Specimens Used as Legal Evidence
9 Chapter 9: Non-Blood Collection and Preanalytical Errors
9.1 Urine Collection Types and Patient Instruction 9.2 Urine Suitability, Storage, Preservatives, and Rejection 9.3 Other Specimens and Time/Temperature Requirements 9.4 Shipping, Slide Prep, Preanalytical Errors, and Complications
10 Chapter 10: Clinical Chemistry
10.1 Clinical Chemistry Terminology and Test Families 10.2 Chemistry Instrumentation, Cleaning, and Maintenance 10.3 Point-of-Care and Waived Chemistry Testing 10.4 Toxicology Within CMLA Scope
11 Chapter 11: Hematology and Coagulation
11.1 Hematology Terminology, Blood Functions, and Cell Types 11.2 Hematology Instrumentation, QC, and Calibration 11.3 Coagulation: PT, PTT, INR, Heparin, and Warfarin 11.4 Point-of-Care and Waived Hematology Tests
12 Chapter 12: Immunology, Serology, and Immunohematology
12.1 Antigen-Antibody Principles 12.2 Blood Types, Rh, and Immunohematology Basics 12.3 Waived Immunology, Serology, and Immunohematology Procedures
13 Chapter 13: Microbiology
13.1 Microbiology Terminology and Specimen Appropriateness 13.2 Aseptic Processing, Storage, and Transport of Micro Specimens 13.3 Media, Cultures, and Procedure Matching 13.4 Stains, KOH, Wet Preps, Reagents, and Controls
14 Chapter 14: Urinalysis and Microscopy
14.1 Urinalysis Terminology 14.2 Waived Urinalysis Procedures and Specimen Handling 14.3 Microscopy Parts, Magnification, Wet Prep, and Cleaning
15 Chapter 15: Basic Anatomy and Physiology
15.1 Anatomy Relevant to Laboratory Testing 15.2 Physiology Relevant to Laboratory Testing
16 Chapter 16: Legal, Ethical, and HIPAA Foundations
16.1 Consent, ABN, Test Ordering, and PPM Restrictions 16.2 Patient's Bill of Rights, Refusal, and Medicolegal Risk 16.3 Professional Appearance, Conduct, and Social Media 16.4 HIPAA Confidentiality and Record Release
17 Chapter 17: Clerical Skills, Communication, and Critical Values
17.1 Reports, Abnormal Results, and Critical-Value Notification 17.2 HIT Data, Inventory, Expirations, and Billing/Coding 17.3 Patient Instruction, Communication, Telephone, and Time Management
10.3 Point-of-Care and Waived Chemistry Testing
Key Takeaways Explain This Topic AI
Point-of-care tests are within CMLA scope (AMT III.5.C); perform waived clinical chemistry exactly per the IFU after required QC.
Operator lockout blocks testing when QC is overdue or the operator is not certified on that device — never share login IDs to bypass it.
Strip or cartridge lot coding must match the meter; mismatched coding is an IFU failure and can default the method off-label (Chapter 5).
Capillary and venous glucose can differ, especially after a meal; report the specimen type the IFU and SOP require and do not pour serum onto a whole-blood strip.
Hypoglycemia and hyperglycemia at the laboratory's critical thresholds are report-immediately results — notify the authorized provider and document read-back.
Last updated: August 2026
AMT III.5.C is short and binding: know that point-of-care tests are within the laboratory assistant's scope of practice , and perform point-of-care and waived clinical chemistry tests . Sections 10.1–10.2 taught the words and the devices. This section is the patient test: glucose meters, waived A1c, waived lipids, waived electrolytes when they are truly waived, plus the operational traps that make a waived result invalid. Urine chemistry dipsticks overlap Chapter 14; mention them only so you do not confuse a urine glucose pad with a blood glucose meter.
Quick Answer: After patient identification and operator competency, confirm the meter is not lockout-blocked, confirm strip lot coding , collect the IFU specimen (often capillary or venous whole blood ), run the test, and treat critical hypoglycemia or hyperglycemia as report immediately . Do not share operator IDs, do not mismatch strip lots, and do not treat capillary and venous glucose as automatically identical.
POC is in scope — high-complexity chemistry still is not
Point-of-care (POC) testing is laboratory testing performed near the patient rather than on the core-lab analyzer. Many POC chemistry methods are waived ; some POC cartridges are moderate complexity. CMLA performance follows the FDA classification and the laboratory's CLIA certificate, not the fact that the device is small. A handheld cartridge that is moderate complexity is not waived just because it sits on a nursing unit.
You do perform unmodified waived/POC chemistry listed in the SOP after competency. You do not independently run the core-lab chemistry analyzer, dilute a waived specimen to "make it read," or use an unapproved specimen type (Chapter 5). Off-label use still defaults the method to high complexity.
Waived/POC chemistry you must be ready to perform Typical specimen (always read this IFU) CMLA traps
Blood glucose meter Capillary or venous whole blood as named Serum on a whole-blood strip; uncoded strips; lockout bypass
Waived hemoglobin A1c Often EDTA whole blood or a named capillary method Using it off-label as a diagnostic method when the IFU is monitoring only
Waived lipids (cholesterol, sometimes HDL/triglycerides) Capillary whole blood or the named serum/plasma Skipping a required fast; expired cassette
Waived electrolytes Only if that cartridge/meter is FDA-waived Assuming every blood-gas or electrolyte cartridge is waived
Urine dipstick glucose/ketones Fresh urine (Chapter 14) Reporting a urine glucose as a blood BMP glucose
Scenario. A clinic owns a waived glucose meter and a moderate-complexity cartridge system that measures electrolytes. The CMLA performs the glucose per IFU. The CMLA does not independently run the moderate-complexity cartridge unless the laboratory's certificate, personnel rules, and SOP assign that method to an eligible testing person — a CMLA credential alone does not convert complexity.
Operator lockout, competency, and strip coding
Modern meters enforce policy that humans used to skip.
Operator lockout prevents patient testing when QC is overdue, when the operator ID is not certified on that device, or when a critical-error flag is uncleared. Lockout is a safety feature. Bypassing it by borrowing a coworker's barcode, typing a universal code taped to the wall, or switching to "training mode" for a real patient is a reportable failure. Complete QC, complete competency, or use a backup in-control meter under your own valid ID.
Strip or cartridge coding ties the lot's calibration curve to the meter. Some lots use a chip, a barcode on the vial, or a no-code system that still requires you to confirm the vial and meter match. Loading Lot A strips while the meter is coded for Lot B is an IFU failure. It can produce a tight cluster of wrong answers (precise but not accurate — Chapter 4) and is modified use if you ignore the coding step the insert requires.
Store strips in the original vial, cap closed, at the labeled temperature. Do not pour strips into a pocket, a glove, or a plastic cup. Do not use strips that were left open overnight or that expired yesterday "just this once."
Capillary versus venous glucose
Glucose is the highest-volume waived chemistry test and the easiest specimen-type trap.
Capillary (fingerstick) whole blood is what most handheld meters are cleared for. The IFU may exclude neonates, critically ill patients, or arterial/line draws. Those exclusions are population/specimen limitations (Chapter 5), not suggestions.
Venous whole blood may be allowed on some meters; serum or plasma poured from a centrifuged tube is not a capillary drop. Hematocrit and matrix effects change the reading.
Capillary and venous glucose are not automatically identical . After a meal, capillary glucose is often higher than a simultaneous venous plasma glucose. Fasting values are closer. Report the specimen type the SOP requires ("fingerstick whole blood," "venous whole blood") so the clinician does not treat a POC number as a core-lab plasma glucose without context.
Do not alternate sites (forearm versus fingertip) unless the IFU allows it; some alternative sites lag true fingertip changes during rapid hypo- or hyperglycemia.
Scenario. A patient finished breakfast. A fingerstick meter reads 180 mg/dL; a venous plasma glucose drawn minutes later is lower. That discrepancy can be physiologic, not a broken meter. You still report each result with its specimen type. You do not "correct" the meter by pouring SST serum onto the strip to match the lab.
Critical hypoglycemia and hyperglycemia: report immediately
A critical value (panic value) is a result so far from expected that it may indicate a life-threatening state. Glucose is the chemistry analyte you will see at the chair. Hypoglycemia (low glucose) and hyperglycemia (high glucose) at the laboratory's posted thresholds are report-immediately results (Work Area IV.12.G; Chapter 17).
AMT does not publish a numeric glucose panic list. Use the laboratory's critical-value table. Example facility lists often treat glucose below about 50 mg/dL, or above about 400–500 mg/dL, as critical in adults — those figures are examples, not AMT cutoffs, and pediatric or neonatal lists differ. Some meters display HI/LO instead of a number when the result is outside the reportable range; that is still a critical-path result, not a shrug.
When the meter shows a critical or HI/LO glucose:
Do not hide the result or rerun until a "nicer" number appears unless the SOP requires a documented repeat on a new strip with a valid reason (for example an underfilled strip error).
Notify the authorized provider immediately by the SOP route (in person or telephone, not a sticky note).
Document who was notified, the time, the result, the specimen type, and read-back .
Follow any SOP for a confirmatory laboratory glucose — that confirmation does not delay the first notification.
Symptoms (sweating, confusion, unresponsiveness for hypo; extreme thirst or Kussmaul breathing for severe hyper) reinforce urgency but are not required before you notify. The number is enough.
Waived A1c and waived lipids rarely produce the same minute-to-minute panic as glucose, but they still follow lockout, coding, dating, fasting (if required), and intended-use rules. A waived A1c IFU that says monitoring is not a license to diagnose diabetes off-label.
Exam traps
Believing POC chemistry is outside CMLA scope.
Sharing an operator ID to clear lockout.
Mismatched strip lot coding.
Treating capillary and venous glucose as the same specimen.
Pouring serum onto a whole-blood glucose strip.
Charting a critical glucose without immediate notification.
Reporting a urine dipstick glucose as a blood chemistry glucose.
Perform the waived test the insert describes, on the specimen it names, under your own competency, and move critical glucose the same hour you see it.